US2003229214A1PendingUtilityA1

Vaccines comprising synthetic genes

Priority: Feb 22, 1996Filed: Feb 17, 2003Published: Dec 11, 2003
Est. expiryFeb 22, 2016(expired)· nominal 20-yr term from priority
C12N 15/67A61K 2039/51C07K 14/005C07K 2319/00C12N 2740/16122
52
PatentIndex Score
0
Cited by
0
References
0
Claims

Abstract

Synthetic polynucleotides comprising a DNA sequence encoding a peptide or protein are provided. The DNA sequence of the synthetic polynucleotides comprise codons optimized for expression in a nonhomologous host. The invention is exemplified by synthetic DNA molecules encoding HIV env as well as modifications of HIV env. The codons of the synthetic molecules include the projected host cell's preferred codons. The synthetic molecules provide preferred forms of foreign genetic material. The synthetic molecules may be used as a polynucleotide vaccine which provides immunoprophylaxis against HIV infection through neutralizing antibody and cell-mediated immunity. This invention provides polynucleotides which, when directly introduced into a vertebrate in vivo, including mammals such as primates and humans, induces the expression of encoded proteins within the animal.

Claims

exact text as granted — not AI-modified
What is claimed is:  
     
         1 . A synthetic polynucleotide comprising a DNA sequence encoding a peptide or protein, the DNA sequence comprising codons optimized for expression in a nonhomologous host.

Join the waitlist — get patent alerts

Track US2003229214A1 — get alerts on status changes and closely related new filings.

We store only your email — no account needed. See our privacy policy.